Homo sapiens (human): 3569
Help
Entry
3569 CDS
T01001
Symbol
IL6, BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2, IFNB2, IL-6
Name
(RefSeq) interleukin 6
KO
K05405
interleukin 6
Organism
hsa
Homo sapiens (human)
Pathway
hsa01521
EGFR tyrosine kinase inhibitor resistance
hsa01523
Antifolate resistance
hsa04060
Cytokine-cytokine receptor interaction
hsa04061
Viral protein interaction with cytokine and cytokine receptor
hsa04066
HIF-1 signaling pathway
hsa04068
FoxO signaling pathway
hsa04151
PI3K-Akt signaling pathway
hsa04218
Cellular senescence
hsa04620
Toll-like receptor signaling pathway
hsa04621
NOD-like receptor signaling pathway
hsa04623
Cytosolic DNA-sensing pathway
hsa04625
C-type lectin receptor signaling pathway
hsa04630
JAK-STAT signaling pathway
hsa04640
Hematopoietic cell lineage
hsa04657
IL-17 signaling pathway
hsa04659
Th17 cell differentiation
hsa04668
TNF signaling pathway
hsa04672
Intestinal immune network for IgA production
hsa04931
Insulin resistance
hsa04932
Non-alcoholic fatty liver disease
hsa04933
AGE-RAGE signaling pathway in diabetic complications
hsa04936
Alcoholic liver disease
hsa05010
Alzheimer disease
hsa05020
Prion disease
hsa05022
Pathways of neurodegeneration - multiple diseases
hsa05130
Pathogenic Escherichia coli infection
hsa05132
Salmonella infection
hsa05133
Pertussis
hsa05134
Legionellosis
hsa05135
Yersinia infection
hsa05142
Chagas disease
hsa05143
African trypanosomiasis
hsa05144
Malaria
hsa05146
Amoebiasis
hsa05152
Tuberculosis
hsa05161
Hepatitis B
hsa05162
Measles
hsa05163
Human cytomegalovirus infection
hsa05164
Influenza A
hsa05166
Human T-cell leukemia virus 1 infection
hsa05167
Kaposi sarcoma-associated herpesvirus infection
hsa05168
Herpes simplex virus 1 infection
hsa05169
Epstein-Barr virus infection
hsa05171
Coronavirus disease - COVID-19
hsa05200
Pathways in cancer
hsa05202
Transcriptional misregulation in cancer
hsa05321
Inflammatory bowel disease
hsa05323
Rheumatoid arthritis
hsa05332
Graft-versus-host disease
hsa05410
Hypertrophic cardiomyopathy
hsa05417
Lipid and atherosclerosis
Network
nt06160
Human T-cell leukemia virus 1 (HTLV-1)
nt06161
Human immunodeficiency virus 1 (HIV-1)
nt06162
Hepatitis B virus (HBV)
nt06164
Kaposi sarcoma-associated herpesvirus (KSHV)
nt06165
Epstein-Barr virus (EBV)
nt06168
Herpes simplex virus 1 (HSV-1)
nt06169
Measles virus (MV)
nt06171
SARS coronavirus 2 (SARS-CoV-2)
nt06183
Yersinia
nt06219
JAK-STAT signaling (cancer)
nt06227
Nuclear receptor signaling (cancer)
nt06240
Transcription (cancer)
nt06263
Hepatocellular carcinoma
nt06266
Non-small cell lung cancer
nt06276
Chronic myeloid leukemia
nt06360
Cushing syndrome
nt06460
Alzheimer disease
nt06466
Pathways of neurodegeneration
nt06517
TLR signaling
nt06518
JAK-STAT signaling
Element
N00053
Cytokine-Jak-STAT signaling pathway
N00139
FUS-DDIT3 fusion to CEBPB-mediated transcription
N00317
AhR signaling pathway
N00435
TLR1/2/4-NFKB signaling pathway
N00994
AGE-RAGE signaling pathway
N00996
Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway
N01306
AngII-AT1R-NOX2 signaling pathway
N01307
SARS-CoV-2 S to AngII-AT1R-NOX2 signaling pathway
N01556
IL6 family to Jak-STAT signaling pathway
N01566
TLR5-NFKB signaling pathway
Disease
H00084
Graft-versus-host disease
H00286
Crohn disease
H00630
Rheumatoid arthritis
H01479
Castleman disease
H01672
Juvenile idiopathic arthritis
Drug target
Olokizumab:
D12487
Pirfenidone:
D01583
<JP/US>
Pomalidomide:
D08976
<JP/US>
Siltuximab:
D09669
<US>
Sirukumab:
D10080
Vamikibart:
D12929
Ziltivekimab:
D12807
Brite
KEGG Orthology (KO) [BR:
hsa00001
]
09130 Environmental Information Processing
09132 Signal transduction
04630 JAK-STAT signaling pathway
3569 (IL6)
04668 TNF signaling pathway
3569 (IL6)
04066 HIF-1 signaling pathway
3569 (IL6)
04068 FoxO signaling pathway
3569 (IL6)
04151 PI3K-Akt signaling pathway
3569 (IL6)
09133 Signaling molecules and interaction
04060 Cytokine-cytokine receptor interaction
3569 (IL6)
04061 Viral protein interaction with cytokine and cytokine receptor
3569 (IL6)
09140 Cellular Processes
09143 Cell growth and death
04218 Cellular senescence
3569 (IL6)
09150 Organismal Systems
09151 Immune system
04640 Hematopoietic cell lineage
3569 (IL6)
04620 Toll-like receptor signaling pathway
3569 (IL6)
04621 NOD-like receptor signaling pathway
3569 (IL6)
04623 Cytosolic DNA-sensing pathway
3569 (IL6)
04625 C-type lectin receptor signaling pathway
3569 (IL6)
04659 Th17 cell differentiation
3569 (IL6)
04657 IL-17 signaling pathway
3569 (IL6)
04672 Intestinal immune network for IgA production
3569 (IL6)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
3569 (IL6)
05202 Transcriptional misregulation in cancer
3569 (IL6)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
3569 (IL6)
05161 Hepatitis B
3569 (IL6)
05171 Coronavirus disease - COVID-19
3569 (IL6)
05164 Influenza A
3569 (IL6)
05162 Measles
3569 (IL6)
05168 Herpes simplex virus 1 infection
3569 (IL6)
05163 Human cytomegalovirus infection
3569 (IL6)
05167 Kaposi sarcoma-associated herpesvirus infection
3569 (IL6)
05169 Epstein-Barr virus infection
3569 (IL6)
09171 Infectious disease: bacterial
05130 Pathogenic Escherichia coli infection
3569 (IL6)
05132 Salmonella infection
3569 (IL6)
05135 Yersinia infection
3569 (IL6)
05133 Pertussis
3569 (IL6)
05134 Legionellosis
3569 (IL6)
05152 Tuberculosis
3569 (IL6)
09174 Infectious disease: parasitic
05146 Amoebiasis
3569 (IL6)
05144 Malaria
3569 (IL6)
05142 Chagas disease
3569 (IL6)
05143 African trypanosomiasis
3569 (IL6)
09163 Immune disease
05323 Rheumatoid arthritis
3569 (IL6)
05321 Inflammatory bowel disease
3569 (IL6)
05332 Graft-versus-host disease
3569 (IL6)
09164 Neurodegenerative disease
05010 Alzheimer disease
3569 (IL6)
05020 Prion disease
3569 (IL6)
05022 Pathways of neurodegeneration - multiple diseases
3569 (IL6)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
3569 (IL6)
05410 Hypertrophic cardiomyopathy
3569 (IL6)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
3569 (IL6)
04932 Non-alcoholic fatty liver disease
3569 (IL6)
04931 Insulin resistance
3569 (IL6)
04933 AGE-RAGE signaling pathway in diabetic complications
3569 (IL6)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
3569 (IL6)
01523 Antifolate resistance
3569 (IL6)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:
hsa04052
]
3569 (IL6)
Cytokines and neuropeptides [BR:
hsa04052
]
Cytokines
Interleukins
3569 (IL6)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
IL6
IL11
IL23
Phage_int_SAM_1
GCSF
Motif
Other DBs
NCBI-GeneID:
3569
NCBI-ProteinID:
NP_000591
OMIM:
147620
HGNC:
6018
Ensembl:
ENSG00000136244
UniProt:
P05231
Q75MH2
B4DVM1
Structure
PDB
LinkDB
All DBs
Position
7:22727200..22731998
Genome browser
AA seq
212 aa
AA seq
DB search
MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYI
LDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLL
EFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQ
AQNQWLQDMTTHLILRSFKEFLQSSLRALRQM
NT seq
639 nt
NT seq
+upstream
nt +downstream
nt
atgaactccttctccacaagcgccttcggtccagttgccttctccctggggctgctcctg
gtgttgcctgctgccttccctgccccagtacccccaggagaagattccaaagatgtagcc
gccccacacagacagccactcacctcttcagaacgaattgacaaacaaattcggtacatc
ctcgacggcatctcagccctgagaaaggagacatgtaacaagagtaacatgtgtgaaagc
agcaaagaggcactggcagaaaacaacctgaaccttccaaagatggctgaaaaagatgga
tgcttccaatctggattcaatgaggagacttgcctggtgaaaatcatcactggtcttttg
gagtttgaggtatacctagagtacctccagaacagatttgagagtagtgaggaacaagcc
agagctgtgcagatgagtacaaaagtcctgatccagttcctgcagaaaaaggcaaagaat
ctagatgcaataaccacccctgacccaaccacaaatgccagcctgctgacgaagctgcag
gcacagaaccagtggctgcaggacatgacaactcatctcattctgcgcagctttaaggag
ttcctgcagtccagcctgagggctcttcggcaaatgtag
DBGET
integrated database retrieval system